Guggenheim Starts Faeth Therapeutics (FTH) at Buy, PT $70

September 15, 2026 4:14 PM

Guggenheim analyst Brad Canino initiates coverage on Faeth Therapeutics (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found